Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Theresa Grover

Concepts (346)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Intensive Care Units, Neonatal
37
2026
293
4.050
Why?
Hernias, Diaphragmatic, Congenital
19
2026
221
3.980
Why?
Extracorporeal Membrane Oxygenation
10
2026
390
1.850
Why?
Infant, Newborn
62
2026
6465
1.610
Why?
Infant, Premature
14
2025
620
1.510
Why?
Catheterization, Central Venous
6
2025
123
1.330
Why?
Cross Infection
3
2025
260
1.280
Why?
Bacterial Infections
2
2025
247
1.230
Why?
Bronchopulmonary Dysplasia
10
2024
420
1.060
Why?
Central Venous Catheters
5
2025
53
1.020
Why?
Urinary Tract Infections
4
2025
210
1.010
Why?
Pulmonary Circulation
15
2011
430
0.900
Why?
Gestational Age
17
2025
990
0.890
Why?
Length of Stay
12
2026
1350
0.870
Why?
Enteral Nutrition
4
2025
217
0.840
Why?
Mycoses
1
2025
88
0.840
Why?
Catheter-Related Infections
4
2017
96
0.740
Why?
Gastroschisis
4
2025
33
0.690
Why?
Hypertension, Pulmonary
11
2021
1957
0.590
Why?
Quality Improvement
9
2024
1296
0.590
Why?
Catheterization, Peripheral
1
2021
120
0.590
Why?
Bottle Feeding
1
2019
19
0.580
Why?
Fetus
14
2020
804
0.570
Why?
Retrospective Studies
34
2026
17330
0.570
Why?
Infant
27
2026
10091
0.560
Why?
Infant Formula
1
2019
71
0.560
Why?
Hospitals, Pediatric
6
2025
558
0.550
Why?
Vascular Endothelial Growth Factor A
6
2007
552
0.540
Why?
Bacteremia
4
2024
222
0.530
Why?
Practice Guidelines as Topic
6
2024
1582
0.520
Why?
Lung
10
2011
4116
0.510
Why?
Postoperative Complications
5
2025
2977
0.510
Why?
Parenteral Nutrition, Total
1
2017
30
0.510
Why?
Vasodilation
11
2011
521
0.480
Why?
Weight Gain
2
2017
561
0.480
Why?
Sheep
20
2011
876
0.470
Why?
Infant Mortality
3
2026
128
0.460
Why?
Intensive Care, Neonatal
4
2020
43
0.450
Why?
High-Frequency Ventilation
1
2015
45
0.440
Why?
Infant, Premature, Diseases
2
2024
113
0.430
Why?
Developmental Disabilities
1
2018
281
0.430
Why?
Intersectoral Collaboration
1
2015
64
0.420
Why?
Patient Education as Topic
1
2019
777
0.400
Why?
Nitric Oxide Synthase
9
2006
234
0.390
Why?
Tracheostomy
3
2024
142
0.390
Why?
Humans
65
2026
145785
0.380
Why?
Endothelial Growth Factors
2
2002
62
0.370
Why?
Female
55
2026
79045
0.370
Why?
Lymphokines
2
2002
128
0.370
Why?
Anti-Bacterial Agents
4
2024
1925
0.360
Why?
Hospitalization
3
2021
2461
0.350
Why?
Nitric Oxide
10
2011
892
0.350
Why?
Patient Discharge
6
2025
995
0.340
Why?
Surgical Procedures, Operative
1
2014
271
0.340
Why?
Social Determinants of Health
2
2026
309
0.330
Why?
Intercellular Signaling Peptides and Proteins
2
2002
376
0.330
Why?
Pulmonary Artery
11
2011
1129
0.320
Why?
Parents
1
2019
1407
0.310
Why?
Intubation, Intratracheal
2
2024
327
0.310
Why?
Male
34
2026
73012
0.300
Why?
Respiration, Artificial
6
2026
714
0.300
Why?
Databases, Factual
7
2025
1491
0.290
Why?
Hospital Mortality
4
2026
1038
0.290
Why?
Persistent Fetal Circulation Syndrome
2
2011
138
0.290
Why?
Anesthesia
2
2023
257
0.290
Why?
Pregnancy
23
2021
7216
0.270
Why?
Survival Rate
4
2018
2094
0.270
Why?
Patient Care Bundles
2
2019
29
0.260
Why?
Lung Diseases
1
2014
782
0.260
Why?
Nitric Oxide Synthase Type III
6
2007
203
0.250
Why?
Guideline Adherence
4
2025
587
0.250
Why?
Fibrin
1
2007
84
0.240
Why?
Fetal Diseases
3
2004
194
0.240
Why?
Intestinal Atresia
1
2025
17
0.230
Why?
Urea Cycle Disorders, Inborn
1
2026
26
0.230
Why?
Hernia, Diaphragmatic
1
2026
67
0.230
Why?
Hospitals, High-Volume
1
2026
50
0.230
Why?
Jejunum
1
2025
37
0.230
Why?
Guanylate Cyclase
4
2011
38
0.230
Why?
Multivariate Analysis
5
2025
1547
0.230
Why?
Heart Defects, Congenital
2
2026
910
0.220
Why?
Logistic Models
6
2025
2139
0.220
Why?
Pulmonary Alveoli
2
2005
387
0.220
Why?
Infection Control
2
2017
173
0.220
Why?
Ileum
1
2025
112
0.220
Why?
Bradycardia
2
2024
61
0.220
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2007
298
0.210
Why?
Consensus
2
2024
479
0.210
Why?
Anastomotic Leak
1
2024
45
0.210
Why?
Ventilator Weaning
1
2024
40
0.210
Why?
Ductus Arteriosus, Patent
1
2025
52
0.210
Why?
Device Removal
1
2025
142
0.210
Why?
North America
1
2025
304
0.210
Why?
Esophageal Atresia
1
2024
32
0.210
Why?
Stenosis, Pulmonary Vein
1
2024
19
0.210
Why?
Tracheoesophageal Fistula
1
2024
40
0.210
Why?
Blood Culture
1
2024
27
0.200
Why?
Critical Pathways
1
2025
111
0.200
Why?
Cyclic GMP
4
2011
90
0.200
Why?
Clinical Protocols
1
2025
280
0.200
Why?
Severity of Illness Index
6
2026
2933
0.190
Why?
Laryngoscopy
1
2024
121
0.190
Why?
Ductus Arteriosus
6
2008
72
0.190
Why?
Neovascularization, Pathologic
1
2004
287
0.190
Why?
Delphi Technique
1
2024
333
0.180
Why?
Hemangioendothelioma
1
2002
13
0.180
Why?
Infant, Newborn, Diseases
1
2023
115
0.170
Why?
Infant, Small for Gestational Age
2
2025
118
0.170
Why?
Time Factors
7
2024
7134
0.170
Why?
Uterus
1
2002
228
0.170
Why?
Patient Handoff
1
2021
44
0.170
Why?
Retrognathia
1
2020
4
0.160
Why?
Hepatitis B Vaccines
1
2021
43
0.160
Why?
Animals, Newborn
7
2009
896
0.160
Why?
Micrognathism
1
2020
19
0.160
Why?
Neuromuscular Blockade
1
2021
53
0.160
Why?
Hepatitis B
1
2021
66
0.160
Why?
Betamethasone
1
2000
21
0.160
Why?
Benzoates
2
2011
51
0.160
Why?
Analgesia
1
2021
106
0.160
Why?
Vascular Resistance
6
2011
370
0.150
Why?
Ventricular Septum
1
2019
8
0.150
Why?
Carbon Monoxide
1
2000
82
0.150
Why?
Hypothermia
1
2020
53
0.150
Why?
Incidence
2
2018
2934
0.150
Why?
Cooperative Behavior
3
2017
463
0.150
Why?
United States
7
2025
16126
0.150
Why?
Food, Fortified
1
2019
44
0.140
Why?
Geographic Mapping
1
2019
26
0.140
Why?
Airway Obstruction
1
2020
153
0.140
Why?
Blood Pressure
5
2019
1782
0.140
Why?
Neonatology
1
2019
33
0.140
Why?
Receptors, Cytoplasmic and Nuclear
2
2011
209
0.140
Why?
Endothelium, Vascular
1
2005
956
0.140
Why?
Recombinant Proteins
4
2005
1368
0.140
Why?
Animals
22
2011
38106
0.140
Why?
Community-Acquired Infections
1
2020
177
0.130
Why?
Respiratory Insufficiency
1
2021
327
0.130
Why?
Housing
1
2019
142
0.130
Why?
Echocardiography, Doppler
1
2018
115
0.130
Why?
Perioperative Care
1
2020
231
0.130
Why?
Odds Ratio
2
2020
1083
0.130
Why?
Cardiopulmonary Resuscitation
1
2020
339
0.130
Why?
Infant, Very Low Birth Weight
1
2017
75
0.120
Why?
Continuity of Patient Care
1
2019
297
0.120
Why?
Premature Birth
1
2020
390
0.120
Why?
Heart Arrest
1
2020
411
0.120
Why?
Echocardiography
1
2019
648
0.120
Why?
Disease Models, Animal
6
2011
4568
0.120
Why?
Infant, Extremely Premature
1
2017
68
0.120
Why?
Patient Readmission
2
2019
773
0.120
Why?
Patient Transfer
1
2019
211
0.120
Why?
Hemodynamics
6
2011
1118
0.120
Why?
Glucocorticoids
1
2000
532
0.120
Why?
Child
8
2023
22740
0.120
Why?
Antimicrobial Stewardship
1
2018
130
0.120
Why?
Risk Adjustment
1
2016
85
0.110
Why?
Vasoconstriction
2
2008
216
0.110
Why?
Clinical Nursing Research
1
2015
11
0.110
Why?
Ligation
3
2025
91
0.110
Why?
Liver Neoplasms
1
2002
777
0.110
Why?
Communication
1
2021
977
0.110
Why?
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
3
2011
28
0.110
Why?
Enterocolitis, Necrotizing
2
2024
41
0.100
Why?
Enzyme Activation
3
2005
762
0.100
Why?
rho-Associated Kinases
3
2011
82
0.100
Why?
Nitroarginine
5
2006
57
0.100
Why?
Pregnancy Complications, Cardiovascular
2
2004
85
0.100
Why?
Program Evaluation
1
2017
944
0.100
Why?
Premedication
2
2024
45
0.100
Why?
Risk Factors
5
2026
10919
0.090
Why?
Vascular Endothelial Growth Factors
2
2002
78
0.090
Why?
Linear Models
2
2025
849
0.090
Why?
Heart Septal Defects, Ventricular
2
2026
45
0.090
Why?
Mothers
1
2019
766
0.090
Why?
Administration, Inhalation
2
2007
571
0.090
Why?
Isoenzymes
2
2011
295
0.090
Why?
Vasodilator Agents
2
2011
330
0.090
Why?
Pneumonia
1
2018
636
0.090
Why?
Apgar Score
2
2023
22
0.080
Why?
Enzyme Inhibitors
5
2009
821
0.080
Why?
Leadership
1
2015
402
0.080
Why?
Health Services Accessibility
1
2019
1101
0.080
Why?
Sulfones
3
2005
127
0.080
Why?
Pyridines
4
2011
609
0.080
Why?
Chronic Disease
2
2014
1812
0.080
Why?
Infant, Low Birth Weight
2
2022
156
0.080
Why?
Prevalence
3
2024
2875
0.070
Why?
Myocytes, Smooth Muscle
1
2011
271
0.070
Why?
Treatment Outcome
5
2025
11794
0.070
Why?
Serotonin
1
2011
298
0.070
Why?
Magnetic Resonance Imaging
1
2022
3916
0.070
Why?
Pulmonary Wedge Pressure
2
2009
67
0.070
Why?
Amides
2
2006
101
0.070
Why?
Cohort Studies
4
2021
6033
0.070
Why?
Muscle, Smooth, Vascular
3
2009
450
0.060
Why?
Immunohistochemistry
2
2002
1723
0.060
Why?
Procollagen-Proline Dioxygenase
1
2007
27
0.060
Why?
Estradiol
2
2001
515
0.060
Why?
Immediate-Early Proteins
1
2007
46
0.060
Why?
Cardiovascular Agents
1
2008
166
0.060
Why?
Oxadiazoles
3
2011
37
0.060
Why?
Comorbidity
2
2024
1662
0.060
Why?
Case-Control Studies
2
2024
3634
0.060
Why?
Meconium Aspiration Syndrome
1
2026
11
0.060
Why?
Hospitals, Low-Volume
1
2026
26
0.060
Why?
Selenium
1
2025
50
0.060
Why?
Hydroxyeicosatetraenoic Acids
1
2005
35
0.060
Why?
Renal Replacement Therapy
1
2026
100
0.050
Why?
Protein Kinase Inhibitors
2
2008
981
0.050
Why?
Thoracoscopy
1
2024
60
0.050
Why?
Chylothorax
1
2024
20
0.050
Why?
Abnormalities, Multiple
1
2026
199
0.050
Why?
Antibiotic Prophylaxis
1
2025
134
0.050
Why?
Pyrazoles
2
2005
517
0.050
Why?
Anastomosis, Surgical
1
2024
164
0.050
Why?
Birth Weight
1
2007
517
0.050
Why?
Hyperoxia
1
2005
107
0.050
Why?
Body Weight
2
2005
972
0.050
Why?
Continuous Positive Airway Pressure
1
2024
90
0.050
Why?
Noninvasive Ventilation
1
2024
62
0.050
Why?
Intracellular Signaling Peptides and Proteins
1
2006
457
0.050
Why?
Video Recording
1
2024
219
0.050
Why?
Parenteral Nutrition
1
2024
102
0.050
Why?
Chromones
1
2002
43
0.050
Why?
Homeodomain Proteins
1
2007
523
0.050
Why?
Platelet-Derived Growth Factor
1
2003
85
0.050
Why?
Receptors, Vascular Endothelial Growth Factor
1
2002
109
0.050
Why?
Acetaminophen
1
2025
267
0.040
Why?
Morpholines
1
2002
130
0.040
Why?
Clinical Trials as Topic
1
2007
1062
0.040
Why?
Airway Extubation
1
2022
60
0.040
Why?
Drug Administration Schedule
2
2001
782
0.040
Why?
Oligonucleotides
1
2002
153
0.040
Why?
Gastroesophageal Reflux
1
2024
237
0.040
Why?
Prostaglandins
1
2001
94
0.040
Why?
Estrogen Antagonists
1
2001
37
0.040
Why?
Respiration
1
2022
207
0.040
Why?
Artifacts
1
2022
143
0.040
Why?
Cardiac Catheterization
1
2025
559
0.040
Why?
Image Enhancement
1
2022
200
0.040
Why?
Soluble Guanylyl Cyclase
2
2011
15
0.040
Why?
Piperazines
3
2011
375
0.040
Why?
Postoperative Period
1
2021
351
0.040
Why?
Dose-Response Relationship, Drug
3
2011
2028
0.040
Why?
Phosphatidylinositol 3-Kinases
1
2002
383
0.040
Why?
Injections, Intra-Arterial
1
2000
26
0.040
Why?
Protoporphyrins
1
2000
16
0.040
Why?
Prognosis
2
2019
4330
0.040
Why?
Epinephrine
1
2020
158
0.040
Why?
Quinoxalines
2
2011
65
0.040
Why?
Perioperative Period
1
2020
71
0.040
Why?
Benzodiazepines
1
2021
168
0.040
Why?
Injections, Intramuscular
1
2000
146
0.040
Why?
Airway Management
1
2020
81
0.040
Why?
Proteus
1
2019
5
0.040
Why?
Enterobacter
1
2019
9
0.040
Why?
DNA-Binding Proteins
1
2007
1482
0.040
Why?
Pain Management
1
2023
411
0.040
Why?
Transportation of Patients
1
2020
65
0.040
Why?
Colorado
2
2020
4556
0.040
Why?
Aftercare
1
2021
222
0.040
Why?
Body Temperature Regulation
1
2020
105
0.040
Why?
Body Temperature
1
2020
227
0.040
Why?
Hypnotics and Sedatives
1
2021
222
0.040
Why?
RNA, Messenger
1
2007
2805
0.040
Why?
Reference Values
1
2000
798
0.040
Why?
Contrast Media
1
2022
497
0.040
Why?
Benchmarking
1
2020
191
0.030
Why?
Receptors, Estrogen
1
2001
404
0.030
Why?
Blood Vessels
1
2000
167
0.030
Why?
Ultrasonography, Prenatal
1
2020
295
0.030
Why?
Surgical Mesh
1
2018
50
0.030
Why?
Infectious Disease Transmission, Vertical
1
2020
194
0.030
Why?
Cesarean Section
1
2000
230
0.030
Why?
Operating Rooms
1
2020
144
0.030
Why?
Imaging, Three-Dimensional
1
2022
583
0.030
Why?
Sterilization
1
2017
24
0.030
Why?
Program Development
1
2020
368
0.030
Why?
Drug Utilization
1
2018
168
0.030
Why?
Gene Expression Regulation, Developmental
1
2002
910
0.030
Why?
Congenital Abnormalities
1
2018
109
0.030
Why?
Diagnosis, Differential
1
2002
1512
0.030
Why?
Hydrogen-Ion Concentration
1
2018
532
0.030
Why?
Acetylcholine
2
2009
209
0.030
Why?
Risk Assessment
2
2018
3752
0.030
Why?
Regression Analysis
1
2018
1001
0.030
Why?
Patient Care Team
1
2021
697
0.030
Why?
3',5'-Cyclic-GMP Phosphodiesterases
2
2005
17
0.030
Why?
Cyclic Nucleotide Phosphodiesterases, Type 5
2
2005
23
0.030
Why?
Staphylococcus aureus
1
2019
454
0.030
Why?
Sildenafil Citrate
2
2005
60
0.030
Why?
Escherichia coli
1
2019
835
0.030
Why?
Burns
1
2020
374
0.030
Why?
Prenatal Exposure Delayed Effects
1
2001
655
0.030
Why?
Purines
2
2005
187
0.030
Why?
Survival Analysis
1
2017
1378
0.020
Why?
Cells, Cultured
2
2011
4151
0.020
Why?
Vaccination
1
2021
1428
0.020
Why?
Analgesics, Opioid
1
2021
1154
0.020
Why?
Ketanserin
1
2011
12
0.020
Why?
Serotonin 5-HT2 Receptor Antagonists
1
2011
10
0.020
Why?
Hysterotomy
1
2011
9
0.020
Why?
Sertraline
1
2011
27
0.020
Why?
Receptors, Serotonin
1
2011
34
0.020
Why?
Prostaglandin-Endoperoxide Synthases
2
2001
76
0.020
Why?
Nitroprusside
1
2011
71
0.020
Why?
Fluoxetine
1
2011
56
0.020
Why?
Hypertrophy, Right Ventricular
2
2003
149
0.020
Why?
Kidney
1
2018
1497
0.020
Why?
Adrenal Cortex Hormones
1
2013
484
0.020
Why?
Hydrogen Peroxide
1
2011
335
0.020
Why?
Prospective Studies
1
2021
8078
0.020
Why?
Constriction
1
2008
45
0.020
Why?
Indoles
1
2011
507
0.020
Why?
Signal Transduction
3
2006
5226
0.020
Why?
Child, Preschool
1
2022
11868
0.020
Why?
Regional Blood Flow
1
2008
514
0.010
Why?
Phosphoric Diester Hydrolases
1
2004
52
0.010
Why?
Organ Size
1
2005
461
0.010
Why?
Heart Atria
1
2004
141
0.010
Why?
Neovascularization, Physiologic
1
2005
193
0.010
Why?
Drug Combinations
1
2005
396
0.010
Why?
Blood Flow Velocity
1
2004
421
0.010
Why?
Receptor, Platelet-Derived Growth Factor beta
1
2003
31
0.010
Why?
Receptor, Platelet-Derived Growth Factor alpha
1
2003
53
0.010
Why?
Meclofenamic Acid
1
2001
9
0.010
Why?
8-Bromo Cyclic Adenosine Monophosphate
1
2001
18
0.010
Why?
Cyclooxygenase 1
1
2001
27
0.010
Why?
Infusions, Intra-Arterial
1
2001
61
0.010
Why?
Aorta
1
2004
442
0.010
Why?
Cyclooxygenase Inhibitors
1
2001
82
0.010
Why?
Intramolecular Oxidoreductases
1
2001
65
0.010
Why?
Pulmonary Ventilation
1
2001
82
0.010
Why?
Cyclooxygenase 2
1
2001
167
0.010
Why?
Organ Specificity
1
2001
309
0.010
Why?
Ligands
1
2003
668
0.010
Why?
Cytochrome P-450 Enzyme System
1
2001
162
0.010
Why?
Drug Interactions
1
2001
405
0.010
Why?
Physical Stimulation
1
2000
69
0.010
Why?
Rats, Sprague-Dawley
1
2005
2525
0.010
Why?
Stress, Mechanical
1
2001
494
0.010
Why?
Muscle, Smooth
1
2000
153
0.010
Why?
Blotting, Western
1
2001
1184
0.010
Why?
Gene Expression
1
2003
1478
0.010
Why?
Rats
1
2005
5585
0.010
Why?
Grover's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)